Insulin human regular Injection and Tafenoquine Succinate (Arakoda)
Determining the interaction of Insulin human regular Injection and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin regular
Brand name: Humulin R, Myxredlin, Novolin R, HumuLIN R KwikPen
Synonyms: Insulin Regular
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin human regular Injection-Tafenoquine Succinate (Krintafel)
- Insulin human regular Injection-Tafinlar
- Insulin human regular Injection-Tafluprost
- Insulin human regular Injection-Tafluprost ophthalmic
- Insulin human regular Injection-Tagamet
- Insulin human regular Injection-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Insulin inhalation
- Tafenoquine Succinate (Arakoda)-Insulin isophane
- Tafenoquine Succinate (Arakoda)-Insulin isophane and insulin regular
- Tafenoquine Succinate (Arakoda)-Insulin lispro
- Tafenoquine Succinate (Arakoda)-Insulin Lispro (U-100) Cartridges and Pens
- Tafenoquine Succinate (Arakoda)-Insulin Lispro (U-100) Vials